Extended Data Table 6 Percent hepatic fat fraction over time during the SBTP

From: Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial

  1. DB, double blind; IV, intravenous; MRI, magnetic resonance imaging; Q4W, every 4 weeks; SB, single-blind; SBTP, single-blind treatment period; SD, standard deviation.
Back to article page